Ipratropium bromide is primarily used as a bronchodilator in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps to relax the muscles around the airways, making it easier to breathe. It is also effective in treating asthma, particularly in cases where other treatments are not sufficient.

In addition to respiratory conditions, ipratropium bromide is sometimes used to relieve symptoms of rhinorrhea (runny nose) associated with the common cold or allergic rhinitis. It works by reducing the production of mucus in the nasal passages.

The medication is typically administered via inhalation using a nebulizer or an inhaler, ensuring it directly targets the lungs for quick relief. It is often combined with other medications, such as beta-agonists, to enhance its effectiveness in managing respiratory symptoms.

Ipratropium bromide is also used in anesthesia to reduce airway secretions during surgery, helping to maintain clear airways and prevent complications.

Overall, it is a versatile drug that plays a crucial role in improving respiratory function and quality of life for patients with chronic lung conditions.